[recIndex] (https://github.com/johnnybender/adastandards2016/blob/master/index/recIndex.md)

### **Persistence of two or more autoantibodies predicts clinical diabetes and may serve as an indication for intervention in the setting of a clinical trial. Outcomes may include reversion of autoantibody status, prevention of glycemic progression within the normal or prediabetes range, prevention of clinical diabetes, or preservation of residual C-peptide secretion.**
* Unique ID: rec017
* Evidence Letter: A
* Category Name: TYPE 1 DIABETES
* Page: S14
* Feasible: No
* Type: 
* Comments: 

#### Race Codes:

Description | Codes
----------- | -----


#### Ethnicity Codes:

Description | Codes
----------- | -----
|

#### ICD-9 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 Codes:

Description | Codes
----------- | -----
|

#### ICD-10 PCS Codes:

Description | Codes
----------- | -----
|

#### SNOMED Codes:

Description | Codes
----------- | -----
|

#### CPT Codes:

Description | Codes
----------- | -----
|

#### HCPCS Codes:

Description | Codes
----------- | -----
|

#### LOINC Codes:

Description | Codes
----------- | -----
|

#### CVX Codes:

Description | Codes
----------- | -----
|

#### AHFS Medication Class:

Description | Codes
----------- | -----
|

#### RxNorm:

Description | Codes
----------- | -----
|

#### Miscellaneous Codes:

Description | Dictionary | Codes
----------- | ---------- | -----
|

#### Modules:

Module |
------ |
|

#### Implementation:
